Private equity firm Perceptive Advisors led a $55m Series C Funding Round in Dynacure, a bio-technology company. Additional investors include Tekla Capital Management, Andera Partners, Bpifrance, Kurma Partners and Pontifax. “With the support of our outstanding group of investors, this financing positions us well to advance DYN101 through Phase 1/2 clinical evaluation in both adult and pediatric patients and expand our pipeline into other rare muscle disorders to strengthen Dynacure’s growth,” Stephane van Rooijen, Dynacure CEO.